Orphazyme A/S Email Format
Biotechnology ResearchDenmark51-200 Employees
Orphazyme A/S is a global biopharmaceutical company based in Denmark that concentrates on developing therapies for neurodegenerative orphan diseases. It maintains a late-stage drug pipeline and aims to advance treatments that could meaningfully impact patients facing rare, serious conditions. The company is expanding its presence in the United States, including a Chicago-based headquarters, along with offices in Denmark and Switzerland. Operating within the biotechnology research sector, Orphazyme focuses on delivering therapies to a narrowly defined patient population with unmet medical needs. It is publicly traded on Nasdaq Copenhagen and Nasdaq U.S., reflecting its status as an international firm with cross-border operations.